Condition: Atrial Fibrillation · Sponsor: Volta Medical
Atrial Fibrillation (AF) ablation is typically performed in predefined anatomic regions of the left atrium without attempting to identify patient-specific areas of interest. This procedure is referred to as Pulmonary Vein Isolation (PVI). The hypothesis in this Study is that a tailored ablation strategy targeting areas of spatio-temporal dispersion in combination with PVI is superior to an anatomical ablation strategy targeting PVI alone for the treatment of persistent AF.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Grandview Medical Center | Birmingham, Alabama, United States | — |
| Ascension St. Vincent's | Jacksonville, Florida, United States | — |
| Washington University | St Louis, Missouri, United States | — |
| Northwell Health | New York, New York, United States | — |
| New York Presbyterian Queens Hospital | Queens, New York, United States | — |
| Ohio State University | Columbus, Ohio, United States | — |
| Rhode Island Hospital | Providence, Rhode Island, United States | — |
| Inova Fairfax | Falls Church, Virginia, United States | — |
| OLV Aalst | Aalst, Belgium | — |
| UZ Leuven | Leuven, Belgium | — |
| Pôle Santé République | Clermont-Ferrand, France | — |
| Hôpital Saint Philibert | Lomme, France | — |
+ 14 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.